5 patients discontinued treatment due to drug-related adverse events, including ALT elevation, colitis, duodenal ulcer, acute kidney injury, and stomatitis (n = 1 each) (Overman et al., 2017). This evidence concerns the gene GPT and duodenal ulcer.